Adamis Pharmaceuticals Stock Price - ADMP

0.00 (0.0%)
Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
Canadian Level 1 + USA
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Adamis Pharmaceuticals Corporation ADMP NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.00 0.0% 0.4938 0.00 0.00 0.00 0.4938 04:00:00
Bid Price Ask Price Spread Spread % News
0.49 0.5449 0.0549 10.08% - -
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.4938 USD

Adamis Pharmaceuticals Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 36.41M 73.73M 65.25M $ 22.11M $ - -0.55 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% -4.00 11.50%

more financials information »

Adamis Pharmaceuticals News

Date Time Source News Article
5/27/202009:00GlobeNewswire Inc.Adamis Pharmaceuticals Announces Publication of..
5/20/202016:11Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
5/20/202016:10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
5/20/202016:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
5/20/202016:07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
5/20/202016:07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
5/18/202016:58Edgar (US Regulatory)Current Report Filing (8-k)
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ADMP Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.51250.570.4550.4991315721,543-0.0187-3.65%
1 Month0.44350.64930.43020.51979022,152,5310.050311.34%
3 Months0.47770.64930.270.4442991,556,2070.01613.37%
6 Months0.5870.990.270.52387891,140,516-0.0932-15.88%
1 Year1.511.570.270.69571131,145,233-1.02-67.3%
3 Years4.706.450.272.46854,961-4.21-89.49%
5 Years4.1710.980.272.70624,975-3.68-88.16%

Adamis Pharmaceuticals Description

Adamis Pharmaceuticals Corp is a specialty biopharmaceutical company focused on developing and commercializing products in various therapeutic areas, including respiratory disease and allergy. The company's Symjepi (epinephrine) Injection 0.3mg and Symjepi (epinephrine) Injection 0.15 mg products were approved for use in the emergency treatment of acute allergic reactions, including anaphylaxis. It previously announced a distribution and commercialization agreement with Sandoz to market Symjepi in the US. The company is developing additional products, including a sublingual tadalafil product candidate for the treatment of erectile dysfunction, a naloxone injection product for the treatment of opioid overdose, and metered dose inhaler and dry powder inhaler product candidates.
Your Recent History
Adamis Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200603 10:07:23